Emedonline: Telemedicine Medication Management System

描述（由研究者提供）：据估计，药物不依从性每年给美国医疗保健系统造成的损失估计为766亿美元。 大约10%的住院病人与药物问题有关，每年的费用高达500亿美元。 了解不依从的原因并确定帮助患者遵循其方案的方法可能会改善健康结果并降低相关成本。 我们建议确定药物管理系统是否可以提高老年高血压患者的依从性。药物管理系统，称为Emedonline，使用标准的蜂窝电话技术，以编程的时间间隔打电话给病人，提供语音，文本和图形指示服用处方药，并分发药物。它特别侧重于修改社会互动因素，并提供一个工具，以加强管理过程。 我们已经确定了实现第一阶段和第二阶段目标的三个关键目标：1。开发Emedonline，以促进医疗保健提供者的处方用药方案，并促进患者的用药依从性。 2.评估医疗保健提供者、药剂师和患者对服务的可接受性。 3.评估对服药依从性，感知社会支持和控制健康命运的感觉的影响。 在第一阶段，我们将通过医疗服务提供者，药剂师和患者的样本焦点小组检查要求;开发Emedonline系统的原型;使用样本进行概念测试;并为第二阶段开发创建详细的规范。

DESCRIPTION (provided by investigator): Medication non-compliance is estimated to cost the US healthcare system an estimated $76.6 billion a year. Approximately 10% of hospital admissions are related to medication issues, costing up to $50 billion annually. Understanding the causes of noncompliance and identifying methods to help patients follow their regimens may improve health outcomes and reduce related costs. We propose to determine whether a medication management system improves compliance among elderly patients being treated for hypertension. The medication management system, called Emedonline, uses standard cellular phone technology to call patients at programmed intervals, gives voice, text, and graphic instructions for taking prescribed medications, and dispenses the medications. It focuses specifically on modifying social interaction factors and providing a tool to enhance the administration process. We have identified three key objectives toward achieving Phase I and Phase II goals: 1. Develop Emedonline to facilitate prescribing medication regimens for healthcare providers, and facilitate medication compliance for patients. 2. Assess the acceptability of the service among healthcare providers, pharmacists, and patients. 3. Evaluate effects on medication compliance, perceived social support, and feelings of control over health destiny. During Phase I, we will examine requirements through focus groups with a sample of healthcare providers, pharmacists, and patients; develop a prototype of the Emedonline system; conduct a concept test with the sample; and create detailed specifications for Phase II development.